Lonza Group AG Share Price Swiss Exchange
Equities
CH0013841017
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
||
495.3 CHF | 0.00% |
05-14 | Swiss Market Index Edges Up Ahead of Inflation Report | MT |
05-14 | Global markets live: Apple, Sony, Vodafone, Booking, Walmart... |
Sales 2024 * | 6.66B 7.42B 582B | Sales 2025 * | 7.63B 8.5B 667B | Capitalization | 35.7B 39.78B 3,123B |
---|---|---|---|---|---|
Net income 2024 * | 893M 995M 78.1B | Net income 2025 * | 1.11B 1.23B 96.81B | EV / Sales 2024 * | 5.77 x |
Net Debt 2024 * | 2.72B 3.03B 237B | Net Debt 2025 * | 3.32B 3.7B 290B | EV / Sales 2025 * | 5.12 x |
P/E ratio 2024 * |
40.5
x | P/E ratio 2025 * |
32.4
x | Employees | - |
Yield 2024 * |
0.9% | Yield 2025 * |
1.06% | Free-Float | 96.79% |
Latest transcript on Lonza Group AG
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 24/04/17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 30/11/21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 31/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 15/04/14 |
Director/Board Member | 66 | 15/04/14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 04/05/22 |
1st Jan change | Capi. | |
---|---|---|
+48.67% | 56.95B | |
-6.93% | 39.32B | |
-4.42% | 28.37B | |
+12.01% | 26.45B | |
-18.08% | 19.41B | |
+29.69% | 12.54B | |
+25.11% | 12.21B | |
-0.21% | 12.15B | |
-11.32% | 11.05B |